Thymosin enhances the production of IL-1 alpha by human peripheral blood monocytes.
Hu. S K SK; Badamchian. M M; Mitcho. Y L YL; Goldstein. A L AL
Key Findings
- TF5 stimulates dose‑dependent production of IL‑1 alpha by human monocytes
- The IL‑1 activity is blocked by anti‑IL‑1 alpha antibodies, confirming its identity
- The effect is not due to thymosin‑alpha‑1 but to other peptide(s) in a basic TF5 fraction
- Injecting TF5 in mice induces membrane‑bound IL‑1 on peritoneal cells
Practical Outcomes
- TF5 or similar thymic extracts might be used to boost innate immune signaling, but thymosin‑alpha‑1 alone likely won’t have this effect. For biohackers, the data suggest caution: the beneficial immune boost comes from unknown components, not the marketed peptide, and proper dosing or safety isn’t established yet.
Summary
The study shows that a thymic extract called TF5 can make immune cells release more of a signaling molecule called IL‑1 alpha, but this effect isn’t caused by the well‑known peptide thymosin‑alpha‑1. It works in a dose‑dependent way in lab‑grown human cells and also triggers a related response in mice.
Abstract
Incubation of human peripheral blood monocytes (PBM) with a partially purified thymic preparation, thymosin fraction (TF5), results in a dose dependent production of an interleukin-1 (IL-1)-like factor. The biological activity of this factor can be blocked by anti-IL-1 alpha, but not by anti-IL-1 beta which neutralizes bacterial induced IL-1 activity. Studies with further purified TF5 fractions show that this activity is not due to the well-characterized peptide, thymosin alpha 1 (T alpha 1), but rather a new thymosin peptide(s) isolated from a more basic fraction. Intraperitoneal injection of TF5 also induces the expression of a membrane-bound IL-1 (mIL-1) on mouse peritoneal cells. This study provides the first evidence that TF5 can influence macrophage activity directly by enhancing IL-1 production. This observation may help explain the mechanism by which TF5 modulates immune responses. These results also point to a more selective role for thymic hormones, growth factors and cytokines which may trigger macrophages to secrete different forms of IL-1, which can then regulate either immune and/or inflammatory processes.
Study Information
pubmed
1989